InSyBio is a disruptor to Precision Medicine & Nutrition through effective personalization tests empowered with machine-learning.
InSyBio has raised $100K in total funding. The most recent round was Series A. The last funding was announced in July 2023.
InSyBio's investors include Loyal VC.
InSyBio is headquartered in Narragansett, United States.
InSyBio is a disruptor to Precision Medicine & Nutrition through effective personalization tests empowered with machine-learning.
InSyBio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"InSyBio — Funding & Investors." VCBacked, July 1, 2023, https://www.vcbacked.co/company/insybio. Accessed September 14, 2026.
VCBacked. (2023). InSyBio — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/insybio
{{cite web |title=InSyBio — Funding & Investors |url=https://www.vcbacked.co/company/insybio |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated